NEW YORK (GenomeWeb News) – Two investigators at the University of British Columbia have received C$7.2 million (US$6.8 million) in funding to develop a biomarker-based blood test to identify patients with chronic obstructive pulmonary disorder who are most at risk for lung attacks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.